Grasmick Kimberly A, Hu Heng, Hone Emily A, Farooqi Imran, Rellick Stephanie L, Simpkins James W, Ren Xuefang
Department of Neuroscience, Center for Basic and Translational Stroke Research, West Virginia University, Morgantown, USA.
Department of Microbiology, Immunology and Cell Biology, Center for Basic and Translational Stroke Research, West Virginia University, Morgantown, USA.
J Neuroinfect Dis. 2018;9(4). doi: 10.4172/2314-7326.1000283. Epub 2018 Dec 31.
Mitochondrial dysfunction is known to be implicated in stroke, but the complex mechanisms of stroke have led to few stroke therapies. The present study to disrupted mitochondrial oxidative phosphorylation through a known electron transport chain (ETC) uncoupler, Carbonyl cyanide-4 (trifluoromethoxy) phenylhydrazone (FCCP). Analyzing the resulting neurological deficits as well as infarct volume could help determine the role of mitochondria in stroke outcome and determine whether uncoupling the ETC could potentially be a strategy for new stroke therapies. The objective of this study was to determine the effects of uncoupling electron flow on mitochondrial oxidative phosphorylation and stroke infarction.
Cerebral endovascular cells (CECs) were treated with various concentrations of FCCP, and bioenergetics were measured. For the stroke mouse model, FCCP (1 mg/kg, i.p) or vehicle was administered followed by 1-hour transient middle cerebral artery occlusion (tMCAO). Infarct volume was measured after a 23-hour reperfusion, and triphenyl tetrazolium chloride (TTC) staining was used to assess infarct volume.
FCCP significantly decreased basal respiration, ATP turnover, maximal respiration, and spare capacity when the concentration of FCCP was greater than 1000 nM. The mice pretreated with FCCP had a significantly increased infarct volume within the cortex, striatum, and total hemisphere. Mice receiving FCCP had a significantly increased neurological deficit score compared to the vehicle.
FCCP compromised mitochondrial oxidative phosphorylation in CECs in a dose-dependent manner. Uncoupling the electron transport chain with FCCP prior to tMCAO exacerbated stroke infarction in mice.
已知线粒体功能障碍与中风有关,但中风的复杂机制导致几乎没有有效的中风治疗方法。本研究通过一种已知的电子传递链(ETC)解偶联剂羰基氰化物-4-(三氟甲氧基)苯腙(FCCP)来破坏线粒体氧化磷酸化。分析由此产生的神经功能缺损以及梗死体积,有助于确定线粒体在中风预后中的作用,并确定解偶联ETC是否可能成为新的中风治疗策略。本研究的目的是确定电子流解偶联对线粒体氧化磷酸化和中风梗死的影响。
用不同浓度的FCCP处理脑内皮细胞(CECs),并测量生物能量学指标。对于中风小鼠模型,腹腔注射FCCP(1mg/kg)或溶剂,随后进行1小时的短暂大脑中动脉闭塞(tMCAO)。再灌注23小时后测量梗死体积,并用氯化三苯基四氮唑(TTC)染色评估梗死体积。
当FCCP浓度大于1000nM时,FCCP显著降低基础呼吸、ATP周转率、最大呼吸和备用容量。预先用FCCP处理的小鼠在皮质、纹状体和整个半球内的梗死体积显著增加。与溶剂组相比,接受FCCP的小鼠神经功能缺损评分显著增加。
FCCP以剂量依赖的方式损害CECs中的线粒体氧化磷酸化。在tMCAO之前用FCCP解偶联电子传递链会加重小鼠的中风梗死。